L W Wattenberg. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitorsAnimalsAntineoplastic Agents/pharmacologyAntioxidants/pharmacologyBenzopyrenes/antagonists & inhibitorsBenzyl Compounds/pharmacologyButylated Hydroxyanisole/pharmacologyButylated Hydroxytoluene/pharmacologyCarcinogens/antagonists & inhibitorsDisulfiram/pharmacologyDitiocarb/pharmacologyHumansMicrosomes, Liver/enzymologyMixed Function Oxygenases/antagonists & inhibitorsMixed Function Oxygenases/metabolismSelenium/pharmacologyThiocyanates/pharmacology
Substances: See more » Antineoplastic AgentsAntioxidantsBenzopyrenesBenzyl CompoundsCarcinogensThiocyanatesButylated HydroxytolueneButylated Hydroxyanisole9,10-Dimethyl-1,2-benzanthraceneDitiocarbMixed Function OxygenasesSeleniumDisulfiram
Year: 1978 PMID: 204165 DOI: 10.1016/s0065-230x(08)60088-3
Source DB: PubMed Journal: Adv Cancer Res ISSN: 0065-230X Impact factor: 6.242